Rogozinska, Monika Z.
Clinical & Pharmacology Therapeutics
2018-01-30
http://onlinelibrary.wiley.com/doi/10.1002/cpt.989/full
Pharmaceutical companies have been forever challenged with both rising development costs and the need to find novel ways to differentiate the candidate drugs. Recent advances in digital health (DH) technology, including wearables, in-home clinical devices, and sensors, have enabled a growing array of available data endpoints, making these devices an invaluable tool in clinical programs. The below analysis focuses on advantages and hurdles in implementation of selected DH technologies in drug development.